Joel Linden, Ph.D. was a Professor of the La Jolla Institute for Immunology and a leading expert on adenosine receptors, which are important for regulating inflammation.
Dr. Linden received a B.S. from Brown University in Applied Mathematics and Biology and a Ph.D. from the University of Virginia in Pharmacology.
Dr. Linden has devoted the past 30 years to the study of the pharmacology, physiology and molecular biology of adenosine receptors and has co-authored over 200 papers and over 30 US patents on this subject. Dr. Linden has chaired several NIH study sections, and started a successful biopharmaceutical company, Adenosine Therapeutics.